Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Statements

Latest Statements

Majida, 58, a Syrian patient at MSF’s non-communicable diseases (NCDs) project in Irbid governorate, northern Jordan, close to the Syrian borders, has her blood pressure ochecked by an MSF nurse in one of the two NCDs clinics in Irbid Photograph by Maya Abu Ata
Statement
Statement |
05 February 2025

MSF statement on EB156/7 – Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases

1 min
MSF Flag Photograph by Valérie Batselaere
Statement
Statement |
23 January 2025
Pandemic preparedness Antimicrobial resistance Intellectual property and trade Research and development Tropical & neglected diseases Vaccines

MSF statement on US decision to withdraw from WHO

Rio de Janeiro - Praça da Cruz Vermelha activity Photograph by Mariana Abdalla
Statement
Statement |
16 July 2024
Pandemic preparedness

Pandemic Agreement: MSF Statement at INB10

2 min
Report cover image
Statement |
15 May 2024
Antimicrobial resistance

MSF statement and position paper on UNHLM for AMR

The MSF team prepare medical supplies to transport by motor boat to isolated communities in Delta Amacuro state, northeastern Venezuela. Photo credit: Matias Delacroix
Statement
Statement |
18 March 2024
Pandemic preparedness

Pandemic Agreement: MSF statement on revised draft of negotiating text

2 min
Round of medical staff in the Covid-19 patients ward, Yaoundé, Cameroon. Photo credit: MSF/Vanessa Fodjo
Statement
Statement |
18 February 2024
Pandemic preparedness Intellectual property and trade

Pandemic Accord: MSF statement at INB8 plenary session

2 min
Majida, 58, a Syrian patient at MSF’s non-communicable diseases (NCDs) project in Irbid governorate, northern Jordan, close to the Syrian borders, has her blood pressure ochecked by an MSF nurse in one of the two NCDs clinics in Irbid Photograph by Maya Abu Ata
Statement
Statement |
22 January 2024
Diabetes

MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs)

1 min
Goma, North Kivu province in the Democratic Republic of Congo (DRC), multi-antigen vaccination campaign. Photo credit: MSF/Alexandre Marcou
Statement
Statement |
22 January 2024
Vaccines

MSF statement on EB 154/9 - Immunization Agenda 2030

2 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury